BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 23153509)

  • 1. Down-regulation of NAMPT expression by miR-182 is involved in Tat-induced HIV-1 long terminal repeat (LTR) transactivation.
    Chen XY; Zhang HS; Wu TC; Sang WW; Ruan Z
    Int J Biochem Cell Biol; 2013 Feb; 45(2):292-8. PubMed ID: 23153509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tanshinone II A inhibits tat-induced HIV-1 transactivation through redox-regulated AMPK/Nampt pathway.
    Zhang HS; Chen XY; Wu TC; Zhang FJ
    J Cell Physiol; 2014 Sep; 229(9):1193-201. PubMed ID: 24414799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nicotinamide phosphoribosyltransferase/sirtuin 1 pathway is involved in human immunodeficiency virus type 1 Tat-mediated long terminal repeat transactivation.
    Zhang HS; Sang WW; Wang YO; Liu W
    J Cell Biochem; 2010 Aug; 110(6):1464-70. PubMed ID: 20506278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-217 is involved in Tat-induced HIV-1 long terminal repeat (LTR) transactivation by down-regulation of SIRT1.
    Zhang HS; Wu TC; Sang WW; Ruan Z
    Biochim Biophys Acta; 2012 May; 1823(5):1017-23. PubMed ID: 22406815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-34a is involved in Tat-induced HIV-1 long terminal repeat (LTR) transactivation through the SIRT1/NFκB pathway.
    Zhang HS; Chen XY; Wu TC; Sang WW; Ruan Z
    FEBS Lett; 2012 Nov; 586(23):4203-7. PubMed ID: 23103739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HDAC1/NFκB pathway is involved in curcumin inhibiting of Tat-mediated long terminal repeat transactivation.
    Zhang HS; Ruan Z; Sang WW
    J Cell Physiol; 2011 Dec; 226(12):3385-91. PubMed ID: 21344388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resveratrol inhibited Tat-induced HIV-1 LTR transactivation via NAD(+)-dependent SIRT1 activity.
    Zhang HS; Zhou Y; Wu MR; Zhou HS; Xu F
    Life Sci; 2009 Sep; 85(13-14):484-9. PubMed ID: 19664641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SIRT1 regulates Tat-induced HIV-1 transactivation through activating AMP-activated protein kinase.
    Zhang HS; Wu MR
    Virus Res; 2009 Dec; 146(1-2):51-7. PubMed ID: 19720090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Akt/Nox2/NF-κB signaling pathway is involved in Tat-induced HIV-1 long terminal repeat (LTR) transactivation.
    Zhang HS; Sang WW; Ruan Z; Wang YO
    Arch Biochem Biophys; 2011 Jan; 505(2):266-72. PubMed ID: 21029719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated microRNA-34a in obesity reduces NAD+ levels and SIRT1 activity by directly targeting NAMPT.
    Choi SE; Fu T; Seok S; Kim DH; Yu E; Lee KW; Kang Y; Li X; Kemper B; Kemper JK
    Aging Cell; 2013 Dec; 12(6):1062-72. PubMed ID: 23834033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EGCG inhibits Tat-induced LTR transactivation: role of Nrf2, AKT, AMPK signaling pathway.
    Zhang HS; Wu TC; Sang WW; Ruan Z
    Life Sci; 2012 May; 90(19-20):747-54. PubMed ID: 22480519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SIRT1 regulates HIV transcription via Tat deacetylation.
    Pagans S; Pedal A; North BJ; Kaehlcke K; Marshall BL; Dorr A; Hetzer-Egger C; Henklein P; Frye R; McBurney MW; Hruby H; Jung M; Verdin E; Ott M
    PLoS Biol; 2005 Feb; 3(2):e41. PubMed ID: 15719057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drastic decrease of transcription activity due to hypermutated long terminal repeat (LTR) region in different HIV-1 subtypes and recombinants.
    de Arellano ER; Alcamí J; López M; Soriano V; Holguín A
    Antiviral Res; 2010 Nov; 88(2):152-9. PubMed ID: 20713090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down-regulation of NAMPT expression by mir-206 reduces cell survival of breast cancer cells.
    Hesari Z; Nourbakhsh M; Hosseinkhani S; Abdolvahabi Z; Alipour M; Tavakoli-Yaraki M; Ghorbanhosseini SS; Yousefi Z; Jafarzadeh M; Yarahmadi S
    Gene; 2018 Oct; 673():149-158. PubMed ID: 29886033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Block of Tat-mediated transactivation of tumor necrosis factor beta gene expression by polymeric-TAR decoys.
    Brother MB; Chang HK; Lisziewicz J; Su D; Murty LC; Ensoli B
    Virology; 1996 Aug; 222(1):252-6. PubMed ID: 8806505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the HIV-1 LTR NF-kappaB-proximal Sp site III: evidence for cell type-specific gene regulation and viral replication.
    McAllister JJ; Phillips D; Millhouse S; Conner J; Hogan T; Ross HL; Wigdahl B
    Virology; 2000 Sep; 274(2):262-77. PubMed ID: 10964770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-1 tat transcriptional activity is regulated by acetylation.
    Kiernan RE; Vanhulle C; Schiltz L; Adam E; Xiao H; Maudoux F; Calomme C; Burny A; Nakatani Y; Jeang KT; Benkirane M; Van Lint C
    EMBO J; 1999 Nov; 18(21):6106-18. PubMed ID: 10545121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphorylation of HIV Tat by PKR increases interaction with TAR RNA and enhances transcription.
    Endo-Munoz L; Warby T; Harrich D; McMillan NA
    Virol J; 2005 Feb; 2():17. PubMed ID: 15737233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short communication: a single step assay for rapid evaluation of inhibitors targeting HIV type 1 Tat-mediated long terminal repeat transactivation.
    Chande AG; Baba M; Mukhopadhyaya R
    AIDS Res Hum Retroviruses; 2012 Aug; 28(8):902-6. PubMed ID: 21878060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphorylation of the RAP74 subunit of TFIIF correlates with Tat-activated transcription of the HIV-1 long terminal repeat.
    Zhou M; Kashanchi F; Jiang H; Ge H; Brady JN
    Virology; 2000 Mar; 268(2):452-60. PubMed ID: 10704353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.